Evaluate the safety and tolerability of RMC-6236 in adults with specific RAS mutant advanced solid tumors.

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Revolution Medicines

This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon cancer.

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Oncology Department

Clinical Research Department

Las Vegas, NV

Cancer Research Department

Department of Research and Evaluation

Philadelphia, PA

Dialysis and Nephrology

NRG Oncology

This is a global, randomized, double-blind, placebo-controlled, multicenter phase 3 clinical trial to compare the efficacy and safety of fruquintinib plus best supportive care (BSC) versus placebo plus BSC in participants with refractory metastatic colorectal cancer (mCRC). 691 participants were randomized to one of the following treatment arms in a 2:1 ratio, fruquintinib plus BSC or placebo plus BSC.

A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer

Hematology Oncology Clinic

Charleston, NC

Detroit, MI

Women´s Health Institute

Infectious and Tropical Diseases Service

Infectious Diseases Unit

Ematologia Clinical Trials Unit

HUTCHMED

This study will evaluate the safety, tolerability, drug levels, molecular effects, and clinical activity of MRTX849 (adagrasib) in patients with advanced solid tumors that have a KRAS G12C mutation.

Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1

START San Antonio

Pediatric Endocrinology Department

Plantation, FL

Newport Beach, CA

Beverly Hills, CA

Los Angeles, CA

Neuro-Oncology Department

Seattle, WA

Mirati Therapeutics

This is a multi-site, open-label, Phase II, randomized, trial to compare the efficacy of RO7198457 versus watchful waiting in patients with circulating tumor DNA (ctDNA) positive, surgically resected Stage II/III rectal cancer, or Stage II (high risk)/Stage III colon cancer.

A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer

Brown Dermatology Research - Clinical Trials Unit

Clinical Trials Unit

Clinical Research Unit

Innere Medizin III

BioNTech

The primary objective of the Phase 2 portion of the study is to characterize the clinical activity of maintenance therapy with GRT-C901/GRT-R902 (patient-specific vaccines) in combination with checkpoint inhibitors in addition to fluoropyrimidine/bevacizumab versus a fluoropyrimidine/bevacizumab alone as assessed by molecular response which is based on changes in circulating tumor (ct)DNA. The primary objective of the Phase 3 portion is to demonstrate clinical efficacy of the regimen as assessed by progression-free survival.

A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer

Upstate Greenville Memorial Cardiac Research

Taramac, FL

Gritstone Bio

Find clinical trials for Colon Cancer in Austin, TX

Related conditions:

Colon Cancer trials near Austin, TX, USA:

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US)

A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer (FRESCO-2)

Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1

A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer

A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer

Find clinical trials for Colon Cancer in .css-epvm6{white-space:nowrap;}Austin, TX

Related conditions:

Colon Cancer trials near Austin, TX, USA:

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US)

A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer (FRESCO-2)

Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1

A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer

A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer

Find clinical trials for Colon Cancer in Austin, TX